Followers
0
Following
0
Blog Posts
0
Threads
530
Blogs
Threads
Portfolio
Follower
Following
2020-09-02 22:31 | Report Abuse
He is trap, so ask everyone to buy, he wants to escape.
2020-09-02 20:56 | Report Abuse
If vaccine is out, government will be the one who control the deal, remember, this is not fruit juice or vape ? It is vaccine lah, come on. Cut loss before too late.
2020-09-02 20:54 | Report Abuse
Vaccine is control item, is government call, you think solution can obtain license? Without experience, Without facilities, Without government contracts? Don't dream, see by logic, MoU is not contractually binded.
2020-09-02 18:27 | Report Abuse
The vaccine is still unknown, the share already over goreng . Some more no license yet
2020-09-02 17:49 | Report Abuse
If u think 15% loss is huge, tomorrow will be 30% more drop for you to decide
2020-09-02 16:52 | Report Abuse
Wter fall.. better cut whatever losses possible before worst bottom down tomorrow, solution failed to reply all the queries from bursa, a clear trap. RUN with whatever balance you have now!
2020-09-02 14:10 | Report Abuse
those who trap in 7 and 8 floor, pls cut loss immediately, after today, you will have no change but hold till next 10 years, maybe.
2020-09-02 14:09 | Report Abuse
pasang facilities dalam 1 minggu ?? license 2 tahun baru dapat nanti..
2020-09-02 14:06 | Report Abuse
now you all can see clear picture, it is drug/vaccine, not fruit juice,
many got trap by MoU. ( especially "stockraider mah "")
2020-09-01 21:41 | Report Abuse
Ya, banyak bodoh macam stockraider, vaccine dream on solution. Dia tak tau solution tak ada facilities langsung
2020-09-01 13:33 | Report Abuse
For those trap at 8 floor, you may cut loss before dropping further.
2020-09-01 13:29 | Report Abuse
联合药业(DPHARMA,7148,主板医疗保健组)要透过跨步东盟,实现2025年达到10亿令吉业务的愿景,专精药物与消费保健品是该纯药业集团锐意主打的领域。
主打专精药物保健品
该集团董事经理李奥纳阿里夫接受访问时指出,专精药物占总营收的20%或1亿至1亿2000万令吉,计划要在2至3年内再扩大至30%营收。专精药物包括糖尿病、心脏病、肾病、癌症等药物。
2020-09-01 11:08 | Report Abuse
Among the frontrunners for the fill-and-finish work of the vaccine, Pharmaniaga Bhd and Duopharma Biotech Bhd, are set to compete and deepen their presence in the competitive pharmaceutical space where multinational companies like Pfizer, Merck Sharp & Dohme, Novartis and Sanofi hold the lion share.
Pharmaniaga and Duopharma are government-linked companies. The former is owned by Boustead Holdings Bhd and Lembaga Tabung Angkatan Tentera, and the latter by Permodalan Nasional Bhd.
2020-09-01 11:07 | Report Abuse
The vaccine would be bottled at Duopharma’s plant in Klang, where it has a capacity of close to six to seven million vials per year and able to run an a 24-hour basis. The Klang plant is GMP approved.
Today news
2020-09-01 11:06 | Report Abuse
The vaccine would be bottled at Duopharma’s plant in Klang, where it has a capacity of close to six to seven million vials per year and able to run an a 24-hour basis. The Klang plant is GMP approved.
Today news
2020-08-30 11:21 | Report Abuse
Stockholder, u buy how many billion solution share? Talk like cock.
2020-08-25 12:16 | Report Abuse
by looking at the trend, it should shoot up at lease RM5 this week, no hurry. this is fundamental issue, value investment.
2020-08-25 10:38 | Report Abuse
you may still hold since your buy in at low price , but you will see profit reduce day by day.
2020-08-25 09:58 | Report Abuse
ALL SHARK ALREADY MAKE THE MONEY FROM IKAN BILIS AND THANKS TO STOCKRAIDER.
2020-08-25 09:56 | Report Abuse
SELLL ... DONT BE GREEDY, IT WILL END UP TO 0.15 SOON.
2020-08-25 09:23 | Report Abuse
my 20 years experience told me. CUT LOSS !! final advice.
2020-08-25 09:20 | Report Abuse
SOLUTION REPLY : - SUBJECT TO THIS, SUBJECT TO THAT ???? NO CONCRETE SOLUTION, ALL SUBJECTIVE. when project fail, they blame this, and blame that.... this is the trick.
2020-08-25 09:19 | Report Abuse
what ever vaccine from which country is not the point, the point is - THIS IS THE GOVERNMENT CALL !! NOT MOU
2020-08-25 09:17 | Report Abuse
jump jump, take what ever you can, dont be greedy.
2020-08-25 09:08 | Report Abuse
it is the disaster, if you dont trow now, you may need to keep for your next generation..... RUN !!
2020-08-24 21:47 | Report Abuse
Go and Google how long to set up the vaccine bottling system, and kkm approval process
2020-08-24 20:44 | Report Abuse
tomorrow I announcement also want to sell vaccine, to cure stupid, you want boh ?
2020-08-24 20:43 | Report Abuse
Solution license pun tak ada loh,
Facilities pun tak ada mah,
Approval pun tak ada leh,
Planning only leh,
Kena Bursa question high and low mah,
Answer subject to this, subject to that leh.....
Goreng and tomorrow red alread may.....
2020-08-24 20:26 | Report Abuse
All are only planning only, subject to this, subject to that, no facilities, no licence, no government approval, all open to risk. Boleh percaya ? All main share holder already make their money by selling their share to all of you, and see how long you all can push. Good luck.
2020-08-24 20:21 | Report Abuse
everything is only planning and subject to this, subject to that, boleh percaya meh ?
2020-08-24 20:20 | Report Abuse
We refer to your Company’s announcement dated 19 August 2020, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
1) The total capital and investment outlay required to be committed by SGB in connection with the MOU / proposed new business of the fill and finish of bulk COVID-19 vaccine supplied by CanSinoBIO and the marketing and distribution of the said vaccine in Malaysia (“New Business”), the source(s) of funding and the breakdown thereof.
2) The relevant regulatory approvals, permits and/or licenses required to be obtained in order for SGB to perform its responsibilities under the New Business. To also state whether the Company has secured any of these regulatory approvals, permits and/or licences, and the relevant dates of application and approval.
3) The business risks in connection with the MOU / New Business.
4) The stage of development and production of COVID-19 vaccine by CanSinoBIO.
5) The Company’s future plans and prospects in connection with the collaboration / New Business.
Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.
Yours faithfully,
Listing,
Regulation
Solution kena question kau kau by Bursa.......
2020-08-24 20:11 | Report Abuse
It is obviously trap, you all think drug/ medication licence is "P" driving licence? It may take 5 year to get the approval, as mentioned, it is government call, not MoU settle all.
2020-08-24 19:35 | Report Abuse
Matilah kali ni. Run Run !!!!!
2020-08-24 19:34 | Report Abuse
Bursa question them the MOU !
2020-08-24 19:23 | Report Abuse
run tomorrow before die standing
2020-08-24 19:23 | Report Abuse
We refer to your Company’s announcement dated 19 August 2020, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
1) The total capital and investment outlay required to be committed by SGB in connection with the MOU / proposed new business of the fill and finish of bulk COVID-19 vaccine supplied by CanSinoBIO and the marketing and distribution of the said vaccine in Malaysia (“New Business”), the source(s) of funding and the breakdown thereof.
2) The relevant regulatory approvals, permits and/or licenses required to be obtained in order for SGB to perform its responsibilities under the New Business. To also state whether the Company has secured any of these regulatory approvals, permits and/or licences, and the relevant dates of application and approval.
3) The business risks in connection with the MOU / New Business.
4) The stage of development and production of COVID-19 vaccine by CanSinoBIO.
5) The Company’s future plans and prospects in connection with the collaboration / New Business.
Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.
Yours faithfully,
Listing,
Regulation
2020-08-24 19:17 | Report Abuse
Solution obtain governments license? Answer is NO
2020-08-24 19:15 | Report Abuse
吉隆坡24日讯)发马(PHARMA,7081,主要板医疗保健)代董事经理莫哈末伊其巴尔说,目前正在印度和中国等国家进行临床试验的新冠肺炎疫苗,预计将于明年首季或次季于大马上市。
“多数(疫苗开发者)已宣布会在今年尾推出疫苗,因此我个人认为,他们会先支援当地人,然后再向其他国家提供疫苗。”
他在公司财报表现汇报会上说,一旦获得政府的批准,并符合大马药剂监管局(NPRA)法规,疫苗就能面市。
同时也是发马总营运长的莫哈末伊其巴尔指出,公司注入200万令吉将目前位于蒲种的小容量注射剂(SVI)工厂,重新规划为新冠肺炎疫苗灌封厂。
Solution have any plant?
2020-08-24 09:01 | Report Abuse
those who tray at 0.5 and above, it is good time to RUN RUN !
2020-08-24 08:36 | Report Abuse
Solution is not government mah, Vaccines is control item mah, Vaccines is government call mah.
Solution don't have all the above mah.
Vaccines is not a fruit juice mah.
Solution don't have KKM license mah.
2020-08-23 22:52 | Report Abuse
Glove is with production and revenue, not comparable
2020-08-23 21:50 | Report Abuse
(吉隆坡23日讯)近几个月来,国内大批散户投资者疯炒仙股,就连业务长期蒙受亏损的公司也不放过。对此分析师指出,市场上出现此现象的主要原因,是因为许多散户投资者都是跟风进场,目的就是为了赚快钱。
纵观马股近两个多月来交投最活跃的20股项中,其中15家或75%都是业绩一直亏损的公司。但这些亏钱公司却不断吸引大批散户投资者进场疯炒。
2020-08-23 19:38 | Report Abuse
Main shark start to eat ikan bilis....
2020-08-23 19:37 | Report Abuse
Solution own boss disposed his stock... take profit and run as fast as you can. If you still able to.
2020-08-23 19:36 | Report Abuse
Changes in Director's Interest (Section 219 of CA 2016)
SOLUTION GROUP BERHAD
Information Compiled By KLSE
Particulars of Director
Name MR LIM YONG HEW
Descriptions(Class) Warrants
Details of changes
No
Date of change
No of securities
Type of transaction
Nature of Interest
1
21/08/2020
2,000,000
Disposed
2020-08-23 19:32 | Report Abuse
See tomorrow who run faster before loss out profit. Bye
Stock: [SOLUTN]: SOLUTION GROUP BERHAD
2020-09-02 22:32 | Report Abuse
The 0.8 is over , now going to drop till 0.3